Für Ärzte/Ärztinnen

Ich lege großen Wert auf eine vertrauensvolle Zusammenarbeit mit dem zuweisenden Arzt. Gern stelle ich mich Ihnen auch persönlich vor. Sie erreichen mich unter 0176 52020 181 oder senden Sie mir eine Nachricht, dann rufe ich zurück!

Ergänzende Links zu Studien und anderen Dokumenten:

 

REIZDARM

 

Cedars-Sinai Research Identifies Gut Gas Linked to Diarrhea (Hydrogen Sulfide)

https://www.cedars-sinai.org/newsroom/cedars-sinai-research-identifies-gut-gas-linked-to-diarrhea/

 

Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.

https://www.ncbi.nlm.nih.gov/pubmed/29508268

 

Irritable bowel syndrome and small intestinal bacterial overgrowth: Meaningful association or unnecessary hype

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949258/

 

Update on Irritable Bowel Syndrome Diagnostics and Therapeutics

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969781/

 

IBSchek - The First Clinically Validated Blood Test for IBS with Predominant Diarrhea (IBS-D) and Mixed Symptoms (IBS-M)

http://www.commdx.com/irritable-bowel-syndrome.html

 

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

https://www.ncbi.nlm.nih.gov/pubmed/11151884/

FODMAP

 

Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs (2017)

https://www.ncbi.nlm.nih.gov/pubmed/28740352

 

Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients!

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467063/  (2017)

 

Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918736/  (2016)

 

A diet low in FODMAPs reduces symptoms of irritable bowel syndrome

https://www.ncbi.nlm.nih.gov/pubmed/24076059  (2014)

 

Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome

https://www.ncbi.nlm.nih.gov/pubmed/21615553  (2011)

SIBO

 

Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.

https://www.ncbi.nlm.nih.gov/pubmed/29508268

 

Irritable bowel syndrome and small intestinal bacterial overgrowth: Meaningful association or unnecessary hype

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949258/

 

How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach

https://www.ncbi.nlm.nih.gov/pubmed/26780631

 

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

https://www.ncbi.nlm.nih.gov/pubmed/11151884/

 

Review of rifaximin as treatment for SIBO and IBS

https://www.ncbi.nlm.nih.gov/pubmed/19243285

 

A 14-day elemental diet is highly effective in normalizing the lactulose breath test

https://www.ncbi.nlm.nih.gov/pubmed/14992438

 

Estimating the contribution of acute gastroenteritis to the overall prevalence of irritable bowel syndrome

https://www.ncbi.nlm.nih.gov/pubmed/22523730

 

Update on Irritable Bowel Syndrome Diagnostics and Therapeutics

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969781/

 

Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth.

https://www.ncbi.nlm.nih.gov/pubmed/20937045

Download
Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus
Breath Testing - North American Consensu
Adobe Acrobat Dokument 223.5 KB
Download
Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth
Rifaximin.pdf
Adobe Acrobat Dokument 387.3 KB
Download
A Combination of Rifaximin and Neomycin Is Most Effective in Treating Irritable Bowel Syndrome Patients With Methane on Lactulose Breath Test
Rifaximin - Neomycin.pdf
Adobe Acrobat Dokument 132.1 KB
Download
Herbal Therapy Is Equivalent to Rifaximin for the Treatment of Small Intestinal Bacterial Overgrowth
Herbal Antibiotics - Rifaximin.pdf
Adobe Acrobat Dokument 1.0 MB
Download
A 14-Day Elemental Diet Is Highly Effective in Normalizing the Lactulose Breath Test
Elemental Diet.pdf
Adobe Acrobat Dokument 156.2 KB
Download
Low-Dose Nocturnal Tegaserod or Erythromycin Delays Symptom Recurrence After Treatment of Irritable Bowel Syndrome Based on Presumed Bacterial Overgrowth
Prokinetics for SIBO.pdf
Adobe Acrobat Dokument 290.6 KB
Download
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Prokinetic LDN.pdf
Adobe Acrobat Dokument 4.1 MB
Download
Systematic Review: Cardiovascular Safety Profile of 5-HT4 Agonists Developed for Gastrointestinal Disorders
Prokinetic Prucalopride.pdf
Adobe Acrobat Dokument 267.4 KB
Download
Dr. Siebeckers Behandlungsschema (Mai 2018)
Siebeckers-Behandlungsschema-05-05-18_de
Adobe Acrobat Dokument 2.4 MB
Download
Dr. Siebeckers Vorschläge zur Symptomlinderung
sibo_symptomatic_relief_suggestions_apr_
Adobe Acrobat Dokument 162.8 KB

METHANOGENE

 

Methanobrevibacter smithii is the predominant methanogen in patients with constipation-predominant IBS and methane on breath

https://www.ncbi.nlm.nih.gov/pubmed/22573345

 

Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway

https://www.ncbi.nlm.nih.gov/pubmed/27347377.3

BIOFILM

 

Biofilm formation of mucosa-associated methanoarchaeal strains

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086402/

 

Biofilms: What Have We Learned from the Research?

http://ndnr.com/gastrointestinal/biofilms-what-have-we-learned-from-the-research/

Download
Discussion about the issues surrounding biofilm therapies, Discussion of the safe uses of biofilm Tx with Rx
Dr Anderson re Biofilm-05-31-2016.pdf
Adobe Acrobat Dokument 207.0 KB

MCAS (Mastcell Activation Syndrome)

 

What is Mast Cell Activation Syndrome (MCAS)?

https://www.drtaniadempsey.com/mastcellactivationsyndrome

 

Ein Webinar von Dr. Afrin (in Englisch) zum Thema MCAS gibt es am Seitenende der folgenden Website:

https://www.drtaniadempsey.com/aboutdrafrin

 

Characterization of Mast Cell Activation Syndrome

https://www.ncbi.nlm.nih.gov/pubmed/28262205

 

Meilenstein in der Diagnostik von Mastzellerkrankungen

https://www.ukb.uni-bonn.de/42256BC8002AF3E7/vwWebPagesByID/27D4C009920E64E6C12571FD003AF0D8

 

Fragebogen Mastzell-Erkrankungen - Patientenversion

https://www.humangenetics.uni-bonn.de/de/forschung/forschungsprojekte/mastzellerkrankungen/checklistepatientenversion

 

Full List of Publications and Presentations by Lawrence B. Afrin, M.D.

http://mastcellresearch.com/full-list-of-publications-and-presentations-by-lawrence-b-afrin-md/

Dr. Theoharis C. Theoharides

https://www.mastcellmaster.com/

 

The Mastocytosis Society

https://www.tmsforacure.org/